Aldeyra Therapeutics Inc (ALDX): A Case For Going Higher

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Recently, Yahoo Finance discussed the stock, revealing that Aldeyra Therapeutics Announces Clinical Development Plan for Resubmission of New Drug Application for Reproxalap in Dry Eye Disease.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Aldeyra Therapeutics Inc is $209.09M. A total of 1.06 million shares were traded on the day, compared to an average of 497.84K shares.

In the most recent transaction, Brady Todd C sold 85,324 shares of ALDX for 3.05 per share on Mar 12 ’24. After the transaction, the President and CEO now owns 1,471,298 company shares. In a previous transaction on Mar 12 ’24, Machatha Stephen sold 11,537 shares at 3.16 per share. ALDX shares that Chief Development Officer owns now total 243,495.

Among the insiders who sold shares, Brady Todd C disposed of 97,914 shares on Mar 11 ’24 at a per-share price of $3.27. This resulted in the President and CEO holding 1,556,622 shares of ALDX after the transaction. In another insider transaction, Machatha Stephen sold 18,231 shares at $3.41 per share on Mar 11 ’24. Company shares held by the Chief Development Officer now total 255,032.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ALDX has a high of $11.97 and a low of $1.42.

As of this writing, ALDX has an earnings estimate of -$0.12 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of $0.02 per share and a lower estimate of -$0.21. The company reported an EPS of -$0.14 in the last quarter, which was 41.70% higher than expectations of -$0.24.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ALDX’s latest balance sheet shows that the firm has $229.79M in Cash & Short Term Investments as of fiscal 2021. There were $15.86M in debt and $11.77M in liabilities at the time. Its Book Value Per Share was $2.02, while its Total Shareholder’s Equity was $205.74M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALDX is Buy with a score of 4.60.

Most Popular

Related Posts